Medicines for human purposes; cachets for pharmaceutical purposes; injection (terms considered too vague by the International Bureau - Rule 13(2)(b) of the Common Regulations under the Madrid Agreement and Protocol); tablet (terms considered too vague by the International Bureau - Rule 13(2)(b) of the Common Regulations under the Madrid Agreement and Protocol); API (Active Pharmaceutical Ingredient) (terms considered too vague by the International Bureau - Rule 13(2)(b) of the Common Regulati...